Evening Report: 25 May, 2022
Lauren Evans from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreFNN Content
Lunch Report: 25 May, 2022
Melissa Darmawan from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreMorning Report: 25 May, 2022
Melissa Darmawan from Finance News Network with a look ahead to today’s ASX trading session.
Read MoreEvening Report: 24 May, 2022
Melissa Darmawan from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreLunch Report: 24 May, 2022
Melissa Darmawan from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreMorning Report: 24 May, 2022
Melissa Darmawan from Finance News Network with a look ahead to today’s ASX trading session.
Read MoreEvening Report: 23 May, 2022
Melissa Darmawan from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreLunch Report: 23 May, 2022
Melissa Darmawan from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreMorning Report: 23 May, 2022
Tim McGowen from Finance News Network with a look ahead to today’s ASX trading session.
Read MoreEvening Report: 20 May, 2022
Lauren Evans from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreLunch Report: 20 May, 2022
Melissa Darmawan from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreEvening Report: 19 May, 2022
Melissa Darmawan from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreLunch Report: 19 May, 2022
Melissa Darmawan from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreLunch Report: 18 May, 2022
Melissa Darmawan from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreChimeric Therapeutics (ASX:CHM) Expands Cancer Trials
Chimeric Therapeutics CEO / MD Jennifer Chow provides an update on clinical trial progression and discusses recent agreements with WuXi Advanced Therapies and Be The Match BioTherapies.
Read MoreRadiopharm Theranostics: Developing a portfolio of assets targeting cancer
Radiopharm Theranostics Limited CEO and Managing Director Riccardo Canevari provides an update on the company’s pipeline and discusses the recent licensing of an asset from UCLA.
Read MorePropTech Group Discusses Q3 FY22 Results
PropTech Group Limited (ASX: PTG) Managing Director and Group CEO Joe Hanna discusses drivers behind PropTech’s results, providing an update on the company’s growth strategies.
Read MoreEvening Report: 17 May, 2022
Melissa Darmawan from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreLunch Report: 17 May, 2022
Melissa Darmawan from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreEvening Report: 16 May, 2022
Lauren Evans from Finance News Network with a round-up of the highlights from today’s ASX trading session.
Read MoreLunch Report: 16 May, 2022
Lauren Evans from Finance News Network with all the news from today’s morning trading session on the ASX.
Read MoreAusbil Celebrates 25 Years
Paul Xiradis, Executive Chair and Chief Investment Officer of Ausbil Investment Management, discusses portfolio positioning in the current climate and the outlook for Australian equities.
Read More
